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Peroxidative oxidations of chemical carcinogens including N-substituted aryl compounds could result in their metabolic activation because the products
react with cellular molecules and lead to cytotoxicity, mutagenicity, and carcinogenicity. In vivo, peroxidative activities are chiefly of neutrophilic leuko-
cyte origin. Neutrophils may be attracted to the site(s) of exposure to carcinogen and, via phagocytosis and respiratory burst, release oxidants that cat-
alyze carcinogen activation and/or cause DNA damage. Our studies, presented herein, concern oxidations of carcinogenic N-arylhydroxamic acids,
N-hydroxy-N-2-fluorenylacetamide (N-OH-2-FAA), and N-hydroxy-N-2-fluorenylbenzamide (N-OH-2-FBA), by enzymatic and chemical systems simu-
lating those of neutrophils, myeloperoxidase and hydrogen peroxide (H202) ± halide, and hypohalous acid and halide at the physiologic concentra-
tions (0.1 M Cl and/or 0.1 mM Br) and the pH (4-6.5) of phagocytosis. Studies also concern oxidations of the hydroxamic acids by rat peritoneal
neutrophils stimulated to undergo respiratory burst and release myeloperoxidase in medium-containing 0.14 M Cl- ± 0.1 mM Br-. The metabolites
formed in the presence of exogenous H202 are consistent with two peroxidative mechanisms: one electron-oxidation to a radical that dismutates to
equimolar 2-nitrosofluorene (2-NOF) and the ester of the respective hydroxamic acid and halide-dependent oxidative cleavage, especially efficient in
the presence of Br,to equimolar 2-NOF and the respective acyl moiety. 2-NOF and the esters undergo further enzymatic and nonenzymatic conver-
sions to unreactive products and/or may bind to cellular macromolecules. The results suggest that peroxidative metabolism of N-arylhydroxamic
acids by neutrophils, yielding the potent direct mutagen 2-NOF and the electrophilic esters, occurs in vivo and is involved in the activation and thus
local tumorigenicities of the hydroxamic acids at the site(s) of application. - Environ Health Perspect 1 02(Suppl 6):75-81 (1994)
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Peroxidase-dependent
Metabolism of N-Arylamines:
Significance of Oxidizing
Systems of Leukocyte Origin
Because extrahepatic tissues are frequent
targets ofchemical induction of cancer and
have low levels of cytochrome P450
monooxygenases, alternative systems
involved in metabolic activation ofcarcino-
gens have been sought. Marnett et al. (1)
discovered an enzyme system, prosta-
glandin H synthase (PHS), containing
cyclooxygenase and peroxidase activities
that effected cooxidation of xenobiotics
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during oxidation of arachidonic acid to
prostaglandins. Oxidations of these com-
pounds, termed cosubstrates, were cat-
alyzed by the peroxidase activity of PHS.
Investigations from several laboratories on
activation ofcarcinogenic N-arylamines via
PHS-mediated oxidations have recently
been reviewed (2,3). PHS catalyzed one
electron (le-)-oxidation of N-2-fluore-
namine (2-FA) to nitrogen-centered free
radicals, which yielded dimeric and poly-
meric products and 2-nitrofluorene (2-
NO2F). However, the pathway to 2-NO2F
still remains obscure because its expected
precursors, N-hydroxy-2-FA and 2-nitroso-
fluorene (2-NOF), were not detected
among the products (4). The oxidation of
2-FA by PHS yielded two, as yet uncharac-
terized, adducts with DNA (5) that were
different from N-(deoxyguanosin-8-yl)-2-
FA, which presumably originates from the
nitrenium ion. The ease ofoxidation ofN-
arylamines is altered by substituents that
affect the electron density on the nitrogen.
For example, benzidine (BZ) is a much
better cosubstrate for PHS peroxidase than
2-FA. PHS oxidation ofBZ to BZ diimine,
which may undergo deprotonation to
nitrenium ion, appears to be the source ofa
major DNA adduct, N-(deoxyguanosin-8-
yl)-BZ (6,7). This adduct may be oxidized
in vivo to N,3-(deoxyguanosin-7,8-yl)-BZ.
Adducts consistent with PHS-mediated
oxidation of BZ, 2-naphthylamine, and 2-
FA were found in dog bladder epithelia,
and may be involved in bladder cancer
induction (8,9).
In addition to ubiquitous PHS, perox-
idative activities in human or animal tissues
also may be derived from endogenous per-
oxidase in various cells such as glandular
acinar cells, epithelial and endothelial cells,
and leukocytes (10). Neutrophils, which
constitute 95% of polymorphonuclear
leukocytes (PMNL), contain myeloperoxi-
dase (MPO) (11). MPO is also found in
monocytes or mononuclear phagocytes
(MNL). Eosinophils (3.8% of total
PMNL) and, presumably, mast cells con-
tain eosinophil peroxidase. In various tissue
eosinophilias, eosinophils may be the pre-
dominant infiltrating leukocytes (12).
Their peroxidase activity per cell is
approximately 2.5-fold greater than that of
neutrophils. During phagocytosis, the
leukocytes undergo degranulation, releasing
peroxidase, and a respiratory burst generat-
ing superoxide anion (O°) from the reduc-
tion of° by NADPH oxidase (11). 0° is,
in turn, converted to hydrogen peroxide
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Table 1. Metabolism of carcinogens and drugs containing -NH2 group by oxidizing systems of leukocytes.
Compound Oxidizing systema Metabolite References
4C-Benzidine PMNL +PMA or 4C covalently bound to leukocytic or exogenous DNA (15)
14C-Methylaminoazobenzene PMNL granules or
4C-N-2-Fluorenamine MPO/H202/Cl- + DNA
14C-N-2-Fluorenamine PMNLC+ PMA or 14C covalently bound to leukocytic or exogenous DNA (16-19)
14C-Acetaminophen MPO/H202/CF- + DNA or
neutrophilsd+ PMA
N-2-Fluorenamine PMNLC lysate + H202+ N-(deoxyguanosin-8-yl)-2-fluorenaminee (20)
+DNA
4-Amino-N-[2-diethylaminoethyl] PMNLC or MNL+ PMA 4-hydroxylamino- and 4-nitro-derivatives (21,22)
benzamide (Procainamide)
4,4'-Diaminodiphenylsulfone
(Dapsone)
4-Amino-N-[5-methyl-3- PMNL orMNLf+ PMA 4-hydroxylamino- and 4-nitro-derivatives (23)
isoxazolyl]benzenesulfonamide
(Sulfamethoxazole)
Abbreviations: PMA, phorbol myristate acetate; PMNL, polymorphonuclear leukocytes (guinea pig peritoneal); MPO, myeloperoxidase; MNL, mononuclear leukocytes (mono-
cytes) (human blood). 'In buffers containing 0.1 to 0.15 M NaCI and 0.05 mM CaCI2 or complete Hank's balanced salt solution, pH 7 to 7.4. bSolubilized with cetyltrimethylam-
d ). elso y 32 f monium bromide. cFrom human blood. Derived from human leukemic cell line (HL-60( Islated by P-postlabeling. 'From human and canine blood.
(H202) through spontaneous or superox-
ide dismutase-catalyzed dismutation. Using
H202, MPO and eosinophil peroxidase
catalyze oxidation ofhalides, preferentially
chloride (CF) and bromide (Br-), respec-
tively, to generate the powerful oxidants
hypohalous and hypobromous acids (HOCI
and HOBr) (13,14). The hypohalous acids
are capable ofhalogenation ofendogenous
amines such as taurine to N-chloro- and N-
bromotaurine, which are more stable oxi-
dants.
MPO-dependent oxidations were
implicated in activation ofN-arylamines to
DNA-bound products by PMNL (Table 1).
In these experiments, incubations of 14C-
labeled BZ, methylaminoazobenzene, 2-FA,
or acetaminophen with phorbol myristate
acetate (PMA)-treated guinea pig or
human PMNL (15-17), or neutrophils of
human leukemic cell line origin (18,19)
resulted in covalent binding ofradioactivity
to leukocytic DNA. The release ofMPO
activity apparently was accomplished by
treatment of leukocytes with PMA in
buffers containing Ca++ or solubilization
with a cationic detergent. The leukocyte
oxidizing system was simulated by MPO
and H202/CF-, which yielded covalently
bound radioactivity to exogenous DNA
(15-17). When 2-FA was reacted with
human neutrophil lysates supplemented
with H202, a single DNA adduct, N-
sdeoxyguanosin-8-yl)-2-FA, was detected by
2P-postlabeling (20). Thus, even though
the mechanism(s) ofoxidation leading to
the electrophile reacting with DNA is
unknown, MPO-dependent metabolism of
carcinogenic N-arylamines leads to their
activation and a DNA adduct associated
with initiation ofcarcinogenesis.
The leukocytes, both PMNL and
MNL, also were used in studies ofmetabo-
lism ofdrugs containing free -NH2 inpara
position to other substitutents (Table 1)
(21-23). The -NH2 group was oxidized to
the hydroxylamino- (detected only in the
presence ofascorbic acid) and then to the
nitro-compound. However, the presumed
intermediary nitroso compound was not
detected from any of the drugs investi-
gated. Simulations ofthese oxidations with
MPO and H202/Cl- yielded the same
metabolites as above and also N-chloramino
derivatives that rearranged to o-chloro-
compounds (24). The MPO-derived oxida-
tion products from drugs containing the
free -NH2 group have been implicated in
adverse effects such as agranulocytosis and
generalized hypersensitivity reactions dur-
ing drug therapy (25). The detection ofthe
hydroxylamino derivatives from these
drugs may be the result ofperoxygenation,
the mechanism recently elucidated for
chloroperoxidase-catalyzed N-oxidation of
p-substituted N-arylamines (26). It is thus
becoming increasingly evident that the
structure of N-arylamine and the type of
the substituent on the aromatic ring are
factors in determining the oxidation products.
The latter may also depend on the type of
peroxidase present and the environment in
a particular tissue.
The above evidence linking leukocytic
peroxidative systems to activation ofN-aryl-
amines suggested that these systems also
might be involved in the activation of the
carcinogenic N-arylhydroxamic acids.
Thus, we investigated the peroxidative
metabolism ofN-hydroxy-N-2-fluorenylac-
etamide (N-OH-2-FAA) and N-hydroxy-
N-2-fluorenylbenzamide (N-OH-2-FBA)
(Figure 1).
Oxidations of Carcinogenic
N-Arylhydroxamic Acids by
Chemical and Enzymatic
Systems Simulating Oxidants
of Leukocyte Origin
A particular characteristic ofN-arylhydrox-
amic acids is their ability to induce tumors at
the sites ofapplication (27). Thus, multiple
ip injections ofan aqueous suspension ofN-
OH-2-FAA (cumulative dose of -0.5
mmole/rat) yielded approximately 62%
peritoneal tumor incidence in male or female
rats. The structural analogue, N-OH-2-
FBA, was more potent since approximately
0.2 mmole/rat yielded pleomorphic sarco-
mas in 75 to 100% rats. The hydroxamic
acids and the oxidation products, 2-NOF
and N-acetoxy-2-FAA (N-AcG-2-FAA),
also were carcinogenic upon sc or im injec-
tions and upon direct application of the
solid to the mammary gland. The sites of
carcinogen application may be infiltrated
by leukocytes in response to physical and
chemical stimuli. It is thus possible that
oxidants released by leukocytes at the sites
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Figure 1. Peroxidative metabolism of carcinogenic N-arylhydroxamic acids. Ac, acetyl (CH3CO); Bz, benzoyl
(C6H5CO); le, one electron; and X, halide.
ofcarcinogen deposits may be involved in
their oxidations and yield products relevant
to their local carcinogenicities.
To investigate this possibility, we first
examined oxidations of the hydroxamic
acids by chemical and enzymatic oxidants
simulating those generated by leukocytes.
Two peroxidative pathways in oxidation of
the hydroxamic acids were considered
(Figure 1): le--oxidation to nitroxyl free
radicals, which dismutate to equimolar C-
nitroso compound and the ester of the
hydroxamic acid, the reaction initially
reported by Bartsch et al. (28-30) for
chemical and enzymatic oxidations of N-
arylacetohydroxamic acids; and hypohalous
acid-catalyzed oxidative cleavage of the
hydroxamic acid to the C-nitroso com-
pound and the respective acid, the reaction
that we reported for halide-dependent
enzymatic oxidations of N-OH-2-FAA
(31). Our earlier investigation also showed
that enzymatically or chemically generated
HOCI, HOBr, or N-bromotaurine, but
not N-chlorotaurine, were capable of oxi-
dation of N-OH-2-FAA via both le and
oxidative cleavage (32). Accordingly, N-
OH-2-FBA would undergo le--oxidation
to a nitroxyl free radical thatwould dismutate
to 2-NOF and the ester N-benzoyloxy-2-
FBA (N-BzO-2-FBA) or halide-dependent
oxidative cleavage or both to 2-NOF and
benzoic acid (BA). Although evidence for
le-oxidation ofN-OH-2-FBA by alkaline
K3Fe(CN)6 in benzene was reported by
Bartsch et al. (28), the presumed N-BzO-
2-FBA was not quantified, and 2-NOF
accounted for only 14%, rather than the
theoretical 50%, of the substrate. Hence,
we reexamined the oxidation of N-OH-2-
FBA by K3Fe(CN)6 and confirmed the
presence of a nitroxyl free radical by elec-
tron spin resonance (ESR) spectroscopy
(Figure 2). However, the area and maximum
amplitude of the signal produced within 1
min from N-OH-2-FBA were approxi-
mately 50 and 60%, respectively, of those
from N-OH-2-FAA, indicating that N-
OH-2-FBA was more slowly oxidized.
Separation ofthe radical dismutation prod-
ucts by HPLC and estimation of their
amounts in the oxidation mixtures based
on the synthesized standards (33) showed
that 2-NOF and the ester accounted for 44
and 40% of the substrate, respectively.
This result confirmed the originally postu-
lated mechanism ofle--oxidation ofN-OH-
2-FBA by a chemical oxidant in
nonaqueous media (28).
In our attempts to examine enzymatic
oxidations of N-OH-2-FBA, we encoun-
tered problems related to the poor solubility
of the hydroxamic acid and instability of
N-BzO-2-FBA, which, in part, underwent
ortho rearrangement (Figure 1) (33).
Therefore, our estimates of the ester
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Figure 2. ESR spectra of nitroxyl-free radicals from
oxidations of N-OH-2-FAA or N-OH-2-FBA. Reaction
mixtures were drawn into the aqueous cell at room
temperature using a vacuum pump. The hydroxamic
acids dissolved in isopropanol were at 50 pM in a total
volume of 2.0 ml. Spectra were recorded 1 min after
initiation of oxidation by addition of 45 mM K3Fe(CN)6
in 0.1 N NaOH to N-OH-2-FAA (A) or N-OH-2-FBA (B)
in benzene. Spectra were recorded 13 to 18 sec after
addition of H202 (50 pM) to N-OH-2-FAA (C) or N-OH-2-
FBA (D) in citrate phosphate buffer, pH 7, with 0.04 or
0.08 guaiacol units of HRP, respectively. Spectra were
recorded 16 to 20 sec after addition of 50 pM HOCI to
citrate phosphate buffer, pH 5 or 6.5, containing 0.1 M
NaCI and N-OH-2-FAA (E) or addition of 50 pM HOBr to
citrate phosphate buffer, pH 4 or 6.5, containing 0.1
mM NaBr and N-OH-2-FAA (F) or N-OH-2-FBA (G).
Spectra were corrected for baseline; scale of spectra A
and B is one-half that of spectra C-G. ESR spectra
were obtained with a Bruker spectrometer ESP 300
(Bruker Analytische Messtechnik GmbH, Rheinstetten,
Germany) operating at a 100-kHz modulation fre-
quency. Scanning was over a 50-G range centering at
3440 G with a 10.5-sec sweep time. Microwave power
was at 5 mWwith receiver gain at 32,000 and modula-
tion amplitude 0.974 G.
formed from N-OH-2-FBA include both
N- and o-BzO-2-FBA. Comparison of Ie -
oxidation ofN-OH-2-FAA and N-OH-2-
FBA by horseradish peroxidase
[(HRP)/H202] at pH 7.0 showed that the
nitroxyl-free radical signal was easily
detectable from N-OH-2-FAA, but barely
detectable from N-OH-2-FBA. The rela-
tive magnitudes ofthe radical signals from
the hydroxamic acids corresponded to the
levels ofthe dismutation products formed
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under similar conditions (Figure 3).
Whereas 2-NOF and N-AcG-2-FAA
accounted for 41 and 29%, respectively, of
N-OH-2-FAA, the respective products 2-
NOF and N-BzO-2-FBA accounted for
only 5 and 2.2% of N-OH-2-FBA and
indicated that N-OH-2-FBA was much
less susceptible to le--oxidation in an
aqueous medium or was inhibitory to the
enzyme. Because decreasing the concentra-
tion of N-OH-2-FBA from 30 to 10 pM
only slightly decreased the amounts ofthe
products (Figure 3), it appears that the
lower concentration was near saturating for
the enzyme.
We also compared oxidations of the
two hydroxamic acids by MPO and H202
+ halide under conditions optimal for prod-
uct formation from N-OH-2-FAA (Figure
4). At pH 6.5, the presence of halide did
not affect the amounts of 2-NOF formed
from N-OH-2-FAA. However, in the
absence ofhalide, the amounts of N-AcO-
FAA were greater, indicating increased level
of le--oxidation. Under these conditions,
the presence of halide increased the
amounts of 2-NOF formed from N-OH-
2-FBA but had no effect on the small
amounts ofits ester. A similar product pro-
file was determined from N-OH-2-FBA
oxidized by MPO and H202/halide at pH
4 and 5 and suggested that the major
source of 2-NOF was halide-dependent
oxidation of N-OH-2-FBA. However, N-
OH-2-FBAyielded approximately 10 times
less 2-NOF than did N-OH-2-FAA, which
was nearly completely converted to 2-
NOF. In the presence ofthe less easily oxi-
dized N-OH-2-FBA, H202 may have led
to inactivation of MPO or destroyed
HOBr, the product of oxidation of Br- by
MPO and H202. As with HRP and H202,
oxidations of N-OH-2-FBA at 30 or 10
pM by MPO and H202 ± halide yielded
similar amounts ofthe products, suggesting
saturation or inhibition ofMPO or both.
Oxidations of the hydroxamic acids by
hypohalous acids also were compared
(Table 2). More 2-NOF, the major product,
was produced from both compounds by
equimolar HOBr at pH 4.0 than by excess
HOCI at pH 5.0, reflecting the greater oxi-
dizing potential of HOBr. The determina-
tion of small amounts of the esters from
oxidations of the hydroxamic acids by
hypohalous acids indicated relatively low
levels of le--oxidation. The ESR signal of
nitroxyl-free radical, indicative of le--oxi-
dation, was detected only during oxidation
of N-OH-2-FAA by HOCI (Figure 2).
With the controlled rate ofoxidation ofN-
OH-2-FAAby HRP and H202, a detectable
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Figure 3. Oxidation of N-OH-2-FAA or NOH-2-FBA by
HRP and H202. The conditions of the incubation and
determination of the metabolites were described previ-
ously (33). Values are the means from three to eight
incubations ± SD.
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Figure 4. Oxidation of N-OH-2-FAA or N-OH-2-FBA by
MPO and H202 ± halide. The conditions of incubations
containing N-OH-2-FBA, 10 pM (solid columns) or 30
pM (open columns) or N-OH-2-FAA, 30 pM (hatched
columns) and, where indicated, 0.1 M Cl or 0.1 mM
Br or both, and determination of the metabolites were
described previously (33). Values are the means from
two to six incubations ± SD.
Table 2. Oxidation of N-OH-2-FAA (A) or N-OH-2-FBA (B) (30 pM) by hypohalous acids.
Product, pMb _ ____ Recovery of
Compound Oxidanta BA 2-NOF Ester Amide A or B, pM
A HOBr -c 26.0 ± 2.60 0.31 ± 0.06 0.30 ± 0.02 4.26 ± 0.60
HOCI - 12.5 ± 0.62 0.14 ± 0.07 0.54± 0.08 16.5 ±0.90
B HOBr 3.68 ± 1.58 11.4 ± 2.23 1.06 ± 0.25 0.13 ± 0.06 9.64± 0.13
HOCI 5.24± 1.91 4.95± 2.88 0.50 ± 0.28 0.30 ± 0.14 22.6± 1.28
Abbreviations: BA, benzoic acid; 2-NOF, 2-nitrosofluorene; HOBr, hypobromous acid; HOCI, hypochlorous acid.
aHOBr (30 pM) + 0.1 mM Br, pH 4.0, or HOCI (3 x 60 pM) + 0.1 M Cl, pH 5.0. bDetermined after 10-min incubation
at 25°C as described previously (33). Values are the means from two to four incubations ± SD. cNot applicable.
level of radical was maintained while
HOCl-catalyzed radical generation was
rapid and brief. With the more powerful
oxidant HOBr, no radical signal from N-
OH-2-FAA and only a faint signal from N-
OH-2-FBA were detected. Based on the
relative amplitudes of the radical signals
and the amounts of the esters, excessive
amounts of 2-NOF were produced from
hypohalous acid-catalyzed oxidations
(Table 2). This supported our original pro-
posal that the major source of2-NOF from
the oxidations of the hydroxamic acid by
HOCI or HOBr is via oxidative cleavage
(32). Likewise, the determinations of
acetate (31) and BA (Table 2) from these
oxidations supported oxidative cleavage of
the hydroxamic acid. BA also was found
from MPO and H202 and Br--catalyzed
oxidation of N-OH-2-FBA (33), which
supported oxidative cleavage as the major
reaction for enzymatically generated HOBr.
We also found that the esters did not con-
tribute to 2-NOF formation. 2-NOF occa-
sionallyyielded small amounts of2-NO2F.
The elucidation of the conditions for
enzymatic or chemical oxidations ofthe N-
arylhydroxamic acids, by oxidants simulating
those of leukocyte origin, prompted our
investigation ofmetabolism ofN-OH-2-FAA
and N-OH-2-FBA by rat PMNL in vitro.
Peroxidative Metabolism of
Cardnogenic N-Arylhydroxamic
Acids by Rat Peritoneal
Neutrophils in Vitro
The carcinogenicities for rat peritoneum of
N-OH-2-FAA, and especially N-OH-2-
FBA, administered ip in aqueous suspen-
sions (27), suggested influx of leukocytes
in response to the foreign compound
deposits. Hence, neutrophils, the predomi-
nant leukocytes, were elicited into rat peri-
toneum through ip injections of proteose
peptone and harvested within 4 hr for
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Figure 5. Neutrophil-derived oxidants. Determinations
of 0°- (0), H202 (L), hypohalous acid (A), and peroxi-
dase activity in guaiacol units (GU) (A) of rat peritoneal
neutrophils suspended in Hank's balanced salt solution
(without Ca++ or Mg'), containing 0.1 mM Br and 10
nM PMA (106 cell/ml) were described previously (34).
Peroxidase activity also was assayed after addition of
0.002% (A----) or 0.02% (A--.--) Cetac. Values
are the means from four to six experiments ± SD.
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studies of metabolism of N-OH-2-FAA
and N-OH-2-FBA. Neutrophils were sus-
pended in Hank's balanced salt solution
(HBSS) (without Ca++ and Mg++), pH 7.2.
In the absence of Ca++, azurophil granules
containing MPO remained intact when the
cells were treated with PMA to effect the
respiratory burst. Addition of a cationic
detergent, cetyltrimethylammonium chlo-
ride (Cetac) at 0.002% or 0.02%, prompted
loss of granule structure. These micro-
scopic changes, observed with the stained
cell preparations, were reflected in the spec-
trum of the oxidants produced by neu-
trophils (Figure 5). Thus, treatment with
PMA in the absence of Ca++ effected the
respiratory burst as shown by O- and
H2G2 production. Some hypohalous acid
but no MPO activity was detected. Addition
ofCetac caused immediate release ofMPO
activity, and the level of the activity was
higher at the higher concentration ofCetac.
Metabolism of N-OH-2-FAA by neu-
trophils was determined before and after
release ofMPO (Figure 6). Because C1- or
Br- or both had a significant effect on the
formation of 2-NOF by MPO and H202
(Figure 4), we examined metabolism ofN-
OH-2-FAA by neutrophils in HBSS
(Figure 6A) and HBSS + 0.1 mM Br-
(Figure 6B). Both the substrate depletion
and metabolite generation were monitored.
In these experiments, N-OH-2-FAA was
added 30 min after initiation ofrespiratory
burst by PMA. However, no substrate
Figure 6. Metabolism of N-OH-2-FAA by rat peritoneal neutrophils. Cells suspended in Hank's balanced salt solu-
tion )HBSS) (panel A) or HBSS containing 0.1 mM Br- (B) (106 cells/ml) were incubated at 37°C in the presence of
10 nM PMA for 30 min. N-OH-2-FAA, 30 pM, was added followed 15 min later by 0.002% Cetac and 50 pM H202.
After 6 min the second aliquot of H202 was added and the mixture incubated for an additional 18 min. Aliquots (0.9
ml) of the incubation mixtures were removed for determination of metabolites and unreacted N-OH-2-FAA (insert
panels) as described previously (34). Values in panels A and B are the means ± SD from three and five experi-
ments, respectively, and were each carried out in duplicate. The effect of 0.1 mM Br on the amounts N-OH-2-FAA
metabolized was significant at p<0.05 at 12, 18, and 24 min after addition of Cetac and H202. Among the metabo-
lites, the effect of Br was significant at p<0.01 for amounts of 2-NOF and 2-NO2F at 6, 12, 18, and 24 min after
addition of Cetac and H202.
depletion or metabolite formation occurred
in the presence of0- or H22 or both, the
products ofthe respiratory burst. Release of
MPO activity by 0.002% Cetac and addi-
tion of 50 pM H202 initiated metabolism
which was augmented by the addition of
the second aliquot ofH202 (no metabolism
was detectable in the absence of H202).
The metabolites included N-AcG-2-FAA,
2-NO2F, 2-FAA, and 2-NOF. The amounts
of2-NO2F, and especially 2-NOF, were
significantly greater in the presence of Br-.
These data were consistent with our previ-
ous findings that N-OH-2-FAA was oxi-
dized chiefly to 2-NOF by MPO and
H202 in the presence of Br- or CI-+Br-
(32,33). The increased level ofoxidation of
N-OH-2-FAA was likely because of the
formation of Br--derived oxidants.
However, Br- had no apparent effect on the
level of le--oxidation because the amounts
ofN-AcG-2-FAA and 2-FAA were similar.
We also have investigated the fate of2-
NOF and N-AcG-2-FAA because their
reactivities in cellular systems might affect
the amounts detected in metabolism studies.
The recovery of2-NOF was only 22% and
decreased with time, especially in active
cells (34). Formation of small amounts of
2-NO2F that was H202-dependent and
both enzymatic and nonenzymatic, could
not account for all the losses of 2-NOF.
The low recoveries of the latter were likely
because of reactivity with cellular compo-
nents such as glutathione or protein binding
or both (27). The recovery of N-AcG-2-
FAA decreased from 75 to 8% in 24 min
(34). In the absence of H202, 73% of the
ester was recovered as 4-OH-2-FAA
(Figure 1). Similarly, large amounts of 4-
OH-2-FAA were formed from N-AcG-2-
FAA incubated with heat-inactivated cell
lysates or in HBSS. The data were consis-
tent with the nonenzymatic conversion of
N-AcG-2-FAA to 4-OH-2-FAA in buffers
containing 0.14 M CF, reported by Scribner
(35). Addition of H202 disrupted the
time-dependent increase in the formation
of 4-OH-2-FAA, which probably was oxi-
dized to a phenoxy radical. However, no 4-
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Figure 7. Deacetylation of N-Ac0-2-FAA or N-OH-2-
FAA by rat peritoneal neutrophils. Cells suspended in
Hank's balanced salt solution containing 0.1 mM Br
and 10 nM PMA (106 cell/ml) were incubated at 37°C
for 30 min before the addition of 0.002% Cetac with
(-) or without (----) 0.1 mM paraoxon. After 15 min,
N-AcO-2-FAA (1) or N-OH-2-FAA (A) at 10 pM was
added (0 point on the graph) and incubation continued
for 24 min. Aliquots (0.9 ml) of the incubation mixtures
were analyzed for unreacted compounds and metabo-
lites as described previously (34). Values are the
means ± SD from two experiments, each carried out in
duplicate. A denotes N-OH-2-FAA formed from N-
AcO-2-FAA.
OH-2-FAA was detected in the peroxi-
dative metabolism of N-OH-2-FAA
(Figure 6), probably because the levels of
N-AcO-2-FAA were too low for its conver-
sion to detectable 4-OH-2-FAA. Small
amounts ofN-AcO-2-FAA were found to
be O-deacetylated to N-OH-2-FAA, espe-
cially in the absence of H202 (Figure 7).
O-Deacetylation was inhibited by paraoxon.
The data were indicative of O-esterase activ-
ity in the neutrophils, which might lead to
regeneration of the substrate from the
product N-AcO-2-FAA (Figure 1). On the
other hand, we found no evidence for N-
deacetylase activity (Figure 7) that would
catalyze formation of N-hydroxy-2-FA
from N-OH-2-FAA and thus lead to 2-
NOF via oxidation ofthe N-hydroxy-2-FA.
Metabolism of N-OH-2-FBA by rat
peritoneal neutrophils was examined under
somewhat modified conditions (Figure 8).
Because ofits low solubility, N-OH-2-FBA
10
8 A x 2-FBA
12 6 * BzO-2-FBA
1.2- 6 t l * 2-NOF
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Figure 8. Metabolism of N-OH-2-FBA by rat peritoneal
neutrophils. Cells suspended in Hank's balanced salt
solution containing 0.1 mM Br (106 cells/ml) were
incubated at 37°C with N-OH-2-FBA, 10 pM, for 30
min. Cetac at 0.02% and 50 pM H202) were added fol-
lowed in 6 min by a second aliquot of H202. The mix-
ture was incubated for an additional 18 min. The
metabolites and the unreacted N-OH-2-FBA (insert
panel) were determined as described previously
(33,34) in 1.8 ml aliquots of the incubation mixtures.
Values are the means ± SD from two experiments,
which were each carried out in duplicate.
was used at 10 pM. During the 30-min
incubation no metabolism took place. After
addition of Cetac (0.02%), negligible
amounts of BzO-2-FBA and 2-NO2F and
small amounts of2-FBA and 2-NOF were
found, suggesting the presence oflow levels
of H202' The data were consistent with
nearly quantitative recovery of the
unchanged substrate (Figure 8) that was
more efficiently extracted in the presence of
the detergent. Additions of H202 signifi-
cantly increased consumption of the sub-
strate and formation of metabolites,
especially of2-FBA and2-NO2F. The latter
was formed, in part, from 2-NOF because
in a separate experiment, approximately
15% ofthe added 2-NOF was found to be
metabolized to 2-NO2F in the presence of
H2*2'
Comparison ofthe metabolite ratios (2-
NOF + 2-NO2F:ester) and the amounts of
the amides obtained from peroxidative
metabolism of N-arylhydroxamic acids by
neutrophils (Figures 6, 8) suggested a
higher level of le--oxidation for N-OH-2-
FBA than N-OH-2-FAA relative to the
oxidative cleavage. Thus, as with the N-
arylamines, the extent ofoxidation and the
product profile are determined by the
structure and, hence, physico-chemical
properties of the N-arylhydroxamic acids.
It is possible that less soluble compounds
such as N-OH-2-FBA remain longer at the
site of application and cause prolonged
infiltrations and oxidant release by leuko-
cytes. Under such circumstances, in addition
to DNA damage from reactive metabolites
of carcinogens, leukocytic oxidants may
cause direct damage to DNA. Demon-
strating that these oxidative processes occur
in vivo is a complex undertaking. Based on
our studies, several approaches appear
viable: a) demonstration ofthe presence of
the more stable derivatives (e.g., 4-OH-2-
FAA, 2-NO2F, o-BzO-2-FBA) (Figure 1);
b) characterization ofboth carcinogen- and
oxidant-induced DNA damage in target
tissues (e.g., peritoneal serosa); c) determi-
nation of the effect of increasing physio-
logic concentration of Br-, a significant
environmental pollutant (36), on the
tumorigenicity of the hydroxamic acids;
and d) demonstration of the interaction
products of the major metabolite 2-NOF
with glutathione, protein, and unsaturated
lipids. Because of the exceptional direct
mutagenicity of 2-NOF in the bacterial
systems (27), it especially merits investiga-
tion. Recent evidence that interaction of
C-nitroso compounds with unsaturated
lipids is a source of0°- (37) or genotoxic 2
products via lipid peroxidation (38) may
be pertinent to the biologic significance of
2-NOF.
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